id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0464-0232,FDA,FDA-2005-N-0464,Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability,Notice,NAD-Notice of Availability of Data,2009-06-01T04:00:00Z,2009,6,2009-06-01T04:00:00Z,2009-06-02T03:59:59Z,2010-08-13T15:19:06Z,E9-12743,0,0,09000064809c1db8
FDA-2005-N-0464-0231,FDA,FDA-2005-N-0464,Guideline re Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability,Other,Guidance,2009-06-01T04:00:00Z,2009,6,2009-06-01T04:00:00Z,,2016-12-08T18:55:55Z,,0,0,09000064809c15da
FDA-2005-N-0464-0230,FDA,FDA-2005-N-0464,Notice of Availability of Data re Guidance for Industry on Providing Regulatory Submissions in Electronic Format-Drug Establishment Registration and Drug Listing; Availability,Notice,Notice of Availability,2009-06-01T04:00:00Z,2009,6,2009-06-01T04:00:00Z,2009-06-02T03:59:59Z,2020-10-10T01:01:27Z,E9-12743,0,0,09000064809c0c71
FDA-2005-N-0464-0233,FDA,FDA-2005-N-0464,Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing,Other,Guidance,2009-05-28T04:00:00Z,2009,5,2009-05-28T04:00:00Z,,2020-10-10T01:01:01Z,,0,0,09000064809c1ad2
FDA-2005-N-0464-0229,FDA,FDA-2005-N-0464,Compressed Gas Association - Supplement Comment [re FDA-2005-N-0464-0080.1],Other,SUP-Supplement,2009-04-16T04:00:00Z,2009,4,2009-04-16T04:00:00Z,,2014-12-16T22:17:42Z,,0,0,090000648095560b
FDA-2005-N-0464-0222,FDA,FDA-2005-N-0464,"Hospira Inc. - ""The Proposed Changes to NDC System Legacy NDC Numbers and Compliance "" (Thomas F. Willer) - Testimony",Other,TS-Testimony,2009-04-15T04:00:00Z,2009,4,2009-04-15T04:00:00Z,,2017-01-18T17:36:54Z,,0,0,0900006480450c46
FDA-2005-N-0464-0223,FDA,FDA-2005-N-0464,"Perrigo - ""Experience with NDC Numbers"" - Testimony",Other,TS-Testimony,2009-04-15T04:00:00Z,2009,4,2009-04-15T04:00:00Z,,2017-01-18T17:38:31Z,,0,0,0900006480450c48
FDA-2005-N-0464-0224,FDA,FDA-2005-N-0464,"Consumer Healthcare Products Association (CHPA) - """"FDA Public Meeting – Proposed Changes to the National Drug Code (NDC) Number System"" (Paul J. Larsen) - Testimony",Other,TS-Testimony,2009-04-15T04:00:00Z,2009,4,2009-04-15T04:00:00Z,,2017-01-18T17:40:20Z,,0,0,0900006480450c4a
FDA-2005-N-0464-0226,FDA,FDA-2005-N-0464,"Guidance for Industry Providing Regulatory Submissions in Electronic
Format -Drug Establishment Registration and Drug Listing",Other,GDL-Guidance (Supporting and Related Materials),2009-04-15T04:00:00Z,2009,4,2009-04-15T04:00:00Z,,2019-10-17T19:56:23Z,,0,0,0900006480667d76
FDA-2005-N-0464-0225,FDA,FDA-2005-N-0464,"AABB - ""National Drug Codes for HCT/Ps"" (M. Allene Carr-Greer) - Testimony",Other,TS-Testimony,2009-04-15T04:00:00Z,2009,4,2009-04-15T04:00:00Z,,2017-01-18T17:41:41Z,,0,0,0900006480450c4f